Shares of Consort Medical plc (NASDAQ:CSRMY) have been given a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating. Consort Medical plc’s rating score has improved by 66.7% from three months ago as a result of various analysts’ upgrades and downgrades.

Zacks has also assigned Consort Medical plc an industry rank of 101 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research lowered shares of Consort Medical plc from a “buy” rating to a “hold” rating in a research report on Wednesday, June 14th.

Consort Medical plc (NASDAQ:CSRMY) remained flat at $15.00 during trading on Thursday. Consort Medical plc has a 12-month low of $12.90 and a 12-month high of $15.00. The stock has a market cap of $733.70 million and a P/E ratio of 25.51. The stock has a 50-day moving average price of $14.76 and a 200 day moving average price of $13.71.

TRADEMARK VIOLATION WARNING: This report was first reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at

Consort Medical plc Company Profile

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.

Get a free copy of the Zacks research report on Consort Medical plc (CSRMY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with's FREE daily email newsletter.